This event is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Industry leaders will debate current trends, companies will showcase their latest technologies.
by Phillip Kim
Share
STAY IN THE LOOP
Subscribe to our free newsletter.
🎉 Breaking News from Trutino Biosciences! 🎉 🚀 FDA IND Approval Secured! 🚀 What happens when a small but mighty start-up dreams big? Magic. The […]
Boehringer Ingelheim signed an option to acquire Trutino Biosciences Inc., a San Diego-based biotech company. Led by Phillip Kim, Ph.D., MBA, Founder and […]
Abstract Background An emerging class of new protease-activatable prodrugs designed to enhance on-target activity and reduce off-target toxicity are being actively developed. Cytokines […]
Abstract Recombinant IL-2 (aldesleukin) is a potent T cell proliferation and differentiation factor and is an approved immunotherapy for advanced melanoma and renal […]